Michael Altman and Konstantin Poukalov Resign From Lyra Therapeutics Board

Dow JonesDec 14 06:28

Lyra Health Welcomes Jennifer Schulz as Chief Executive Officer

BusinesswireDec 5 23:05

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

BusinesswireDec 3 21:00

Lyra Therapeutics: Hold Rating Due to Uncertainty in ENLIGHTEN-2 Trial Outcomes

TipRanksNov 14 19:16 · Ratings

Lyra Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results.

BenzingaNov 14 00:04

BTIG Maintains Lyra Therapeutics(LYRA.US) With Hold Rating

Futu NewsNov 13 19:36 · Ratings